Mattia Siciliano
Overview
Explore the profile of Mattia Siciliano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1072
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharbafshaaer M, Siciliano M, Passaniti C, SantElia V, Silvestro M, Russo A, et al.
Orphanet J Rare Dis
. 2025 Mar;
20(1):110.
PMID: 40057753
Background: Cognitive deficits related to frontotemporal dysfunction are common in Amyotrophic Lateral Sclerosis (ALS). Visuospatial deficits, related to posterior cerebral regions, are often underestimated in ALS, though they play a...
2.
Tinazzi M, Geroin C, Siciliano M, Gandolfi M, Di Vico I, De Micco R, et al.
Neurol Sci
. 2025 Feb;
PMID: 39937423
Non-motor symptoms affect over 90% of people with Parkinson's disease at all stages, with pain and fatigue being among the most prevalent yet often neglected in clinical practice. Despite their...
3.
Trojsi F, Canna A, Sharbafshaaer M, di Nardo F, Canale F, Passaniti C, et al.
Eur J Neurol
. 2024 Nov;
32(1):e16540.
PMID: 39529471
Background And Purpose: 'Neurovascular coupling' (NVC) alterations, assessing the interplay between local cerebral perfusion and neural activity within a given brain region or network, may reflect neurovascular unit impairment in...
4.
Papallo S, di Nardo F, Siciliano M, Esposito S, Canale F, Cirillo G, et al.
J Clin Med
. 2024 Sep;
13(18).
PMID: 39336854
: Repetitive transcranial magnetic stimulation (rTMS) has shown therapeutic effects in neurological patients by inducing neural plasticity. In this pilot study, we analyzed the modifying effects of high-frequency (HF-)rTMS applied...
5.
Siciliano M, De Micco R, SantElia V, Goldman J, Chiorri C, Silvestro M, et al.
Parkinsonism Relat Disord
. 2024 Aug;
127:107077.
PMID: 39116635
Introduction: Mild cognitive impairment is a common feature of Parkinson's disease (PD-MCI), even at the earliest disease stages. Growing evidence supports the instability of PD-MCI over time, without a consistent...
6.
Piramide N, De Micco R, Siciliano M, Silvestro M, Tessitore A
Curr Neurol Neurosci Rep
. 2024 Jul;
24(10):461-477.
PMID: 39046642
Purpose Of The Review: In this review, we attempt to summarize the most updated studies that applied resting-state functional magnetic resonance imaging (rs-fMRI) in the field of Parkinsonisms and related...
7.
Vitale C, Rosa R, Agosti V, Siciliano M, Barra G, Maggi G, et al.
J Pers Med
. 2024 Jun;
14(6).
PMID: 38929809
Rolando Toro's Biodanza (SRT) is a therapeutic strategy that uses movement, music, and emotions to induce integrative living experiences. The present study aims to explore the efficacy of a three-month...
8.
Piramide N, De Micco R, di Nardo F, Caiazzo G, Siciliano M, Cirillo M, et al.
J Neural Transm (Vienna)
. 2024 Apr;
131(8):917-929.
PMID: 38661818
Background: In this study, we aimed at investigating the possible association of urinary symptoms with whole-brain MRI resting-state functional connectivity (FC) alterations from distinct striatal subregions in a large cohort...
9.
Siciliano M, Tessitore A, Morgante F, Goldman J, Ricciardi L
Mov Disord
. 2024 Jan;
39(1):17-28.
PMID: 38173220
Background: Subjective cognitive complaints (SCCs) in Parkinson's disease (PD) are reported frequently, but their prevalence and association with changes on objective testing are not fully known. Objective: We aimed to...
10.
Colucci F, Avenali M, De Micco R, Fusar Poli M, Cerri S, Stanziano M, et al.
BMJ Neurol Open
. 2023 Nov;
5(2):e000535.
PMID: 38027469
Background: Heterozygous mutations in the gene, encoding the lysosomal enzyme β-glucocerebrosidase (GCase), are the most frequent genetic risk factor for Parkinson's disease (PD). -related PD (GBA-PD) patients have higher risk...